Which antibiotics are recommended for a specific infection such as typhoid fever, urinary tract infection, or community‑acquired pneumonia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Antibiotic Recommendations by Infection Type

Based on your comprehensive antibiotic list, here are the specific recommendations for the three most commonly queried infections:


Community-Acquired Pneumonia (CAP)

Outpatient/Mild CAP (otherwise healthy adults)

For patients without comorbidities, start with amoxicillin 500-1000 mg every 8 hours OR a macrolide (azithromycin 500 mg daily for 3 days, or clarithromycin 250-500 mg twice daily) 1.

  • Alternative options: Doxycycline 100 mg twice daily 2, 3
  • Duration: 3-5 days minimum if clinical stability achieved 1, 4

Outpatient/Mild CAP (with comorbidities)

Use amoxicillin-clavulanate 1 g every 8 hours PLUS a macrolide (azithromycin or clarithromycin), OR monotherapy with levofloxacin 750 mg daily or moxifloxacin 400 mg daily 1, 3.

  • Comorbidities include: diabetes, heart/lung disease, immunosuppression
  • Fluoroquinolones provide convenient monotherapy with excellent coverage 1

Hospitalized CAP (medical ward)

First-line: IV ceftriaxone 1-2 g daily OR cefotaxime 1-2 g every 8 hours PLUS azithromycin 500 mg daily OR clarithromycin 500 mg twice daily 1, 3, 2.

Alternative: Levofloxacin 750 mg daily OR moxifloxacin 400 mg daily as monotherapy 1, 3.

  • Other options: IV ampicillin-sulbactam 1.5-3 g every 6 hours plus macrolide 1
  • Duration: 5-7 days if clinical stability reached 4
  • Switch to oral when clinically stable (typically 2-3 days) 3

Severe CAP (ICU)

Without Pseudomonas risk: IV ceftriaxone 1-2 g daily OR cefotaxime 1-2 g every 8 hours PLUS azithromycin 500 mg daily 1, 2.

With Pseudomonas risk factors: IV piperacillin-tazobactam 3.375-4.5 g every 6 hours OR cefepime 2 g every 8-12 hours OR meropenem 1 g every 8 hours PLUS ciprofloxacin 400 mg IV every 8 hours OR levofloxacin 750 mg daily 1, 3.

  • Pseudomonas risk factors: structural lung disease, recent hospitalization, recent broad-spectrum antibiotics
  • Alternative for Pseudomonas: Add gentamicin or amikacin to beta-lactam plus macrolide 3
  • Duration: Minimum 5 days, typically 7-10 days 4

Special Pathogens

  • Legionella: Levofloxacin 750 mg daily preferred; azithromycin 500 mg daily alternative 3
  • MRSA suspected: Add vancomycin 15-20 mg/kg every 8-12 hours 5, 1
  • Aspiration pneumonia: Amoxicillin-clavulanate 2 g IV every 6 hours OR clindamycin 600 mg IV every 8 hours 2

Urinary Tract Infections (UTI)

Uncomplicated Cystitis (otherwise healthy women)

First-line: Nitrofurantoin 100 mg four times daily for 5 days OR fosfomycin 3 g single dose 6, 7, 8.

  • These maintain excellent activity despite rising resistance elsewhere
  • Second-line: Cephalexin 500 mg every 6 hours for 5-7 days 6
  • Avoid as first-line: Trimethoprim-sulfamethoxazole and ciprofloxacin due to high resistance rates in many communities 6, 7

Complicated UTI or Pyelonephritis (outpatient)

Ciprofloxacin 500 mg twice daily for 7 days OR levofloxacin 750 mg daily for 5-7 days 6, 7.

Alternative: Ceftriaxone 1 g IV/IM daily (can give single dose then switch to oral cefixime 400 mg twice daily) 6.

  • Use fluoroquinolones only if local resistance <10% and no recent exposure
  • Duration: 5-7 days for pyelonephritis 6

Complicated UTI (hospitalized)

IV ceftriaxone 1-2 g daily OR cefepime 1-2 g every 12 hours 6, 7.

For ESBL-producing organisms: IV meropenem 1 g every 8 hours OR ertapenem 1 g daily 9.

  • Alternatives for ESBL: Piperacillin-tazobactam 3.375-4.5 g every 6 hours (for E. coli only, not Klebsiella) 6
  • Aminoglycosides: Gentamicin 5-7 mg/kg daily OR amikacin 15 mg/kg daily (for UTI only, not systemic infections) 9
  • Duration: 5-7 days 9

Catheter-Associated UTI

Remove or replace catheter if possible, then treat as complicated UTI 8.

  • Same antibiotic choices as complicated UTI above
  • Consider local resistance patterns for catheterized patients

Recurrent UTI Prevention

  • Not covered in provided guidelines; requires separate evaluation

Typhoid Fever (Enteric Fever)

Uncomplicated Typhoid (fully susceptible strains)

Ciprofloxacin 500 mg twice daily for 5-7 days OR levofloxacin 500 mg daily for 5-7 days 10.

Alternatives: Azithromycin 500 mg daily for 7 days OR ceftriaxone 2 g IV/IM daily for 7-14 days 10.

  • Choice depends heavily on local resistance patterns
  • Older agents (chloramphenicol, amoxicillin, trimethoprim-sulfamethoxazole) now widely resistant 10

Fluoroquinolone-Resistant Typhoid

Azithromycin 500 mg daily for 7 days OR ceftriaxone 2 g IV/IM daily for 7-14 days 10.

  • Fluoroquinolone resistance increasingly common in South Asia
  • Azithromycin preferred for outpatient management

Extensively Drug-Resistant (XDR) Typhoid

Azithromycin 500 mg daily for 7-14 days AND/OR meropenem 1 g IV every 8 hours for 10-14 days 10.

  • XDR strains resistant to chloramphenicol, amoxicillin, trimethoprim-sulfamethoxazole, fluoroquinolones, AND third-generation cephalosporins
  • Combination therapy being studied (azithromycin plus cefixime) 10
  • Consider infectious disease consultation

Severe/Complicated Typhoid

IV ceftriaxone 2 g daily for 10-14 days 10.

  • For patients with complications (intestinal perforation, severe sepsis, altered mental status)
  • Switch to oral when clinically stable

Key Clinical Pearls

Resistance Considerations

  • Always check local antibiograms before selecting empiric therapy
  • Avoid using the same antibiotic class if patient had recent exposure (within 3 months)
  • Reserve carbapenems, ceftazidime-avibactam, and colistin for confirmed resistant organisms 9

Duration Principles

  • Shorter is better when clinically appropriate: CAP can be treated for 3-5 days if stable 4
  • Clinical stability criteria: afebrile >24 hours, improving symptoms, tolerating oral intake, normal vital signs
  • Biomarkers (procalcitonin) may guide shorter durations 3

IV to Oral Switch

  • Switch when clinically stable (typically 2-3 days for pneumonia) 3
  • Use same drug class when possible (e.g., IV levofloxacin → oral levofloxacin)
  • No need to observe in hospital after oral switch in most cases 3

Common Pitfalls

  • Don't use fluoroquinolones for simple cystitis when nitrofurantoin or fosfomycin available 6, 7
  • Don't forget atypical coverage in pneumonia: Always include macrolide or fluoroquinolone for hospitalized CAP 1
  • Don't undertreated severe infections: ICU pneumonia needs minimum 5 days, often 7-10 days 4
  • Don't ignore local resistance: Empiric choices must reflect your community's resistance patterns

References

Research

2025 guideline updates for community-acquired pneumonia diagnosis and management.

The American journal of emergency medicine, 2026

Related Questions

What is the recommended empiric antibiotic choice for community-acquired pneumonia in an otherwise healthy outpatient adult?
What are the recommended drug dosing regimens for community‑acquired pneumonia in adults, including first‑line oral therapy, alternatives for penicillin allergy, atypical coverage, inpatient intravenous regimens, dose adjustments for renal impairment, and considerations for elderly patients?
What antibiotic is appropriate for treating a urinary tract infection in a patient taking amiodarone who is allergic to nitrofurantoin (Macrobid) and sulfonamides?
What are the appropriate treatment options for a 54-year-old male with a complicated urinary tract infection caused by Citrobacter freundii that is resistant to trimethoprim‑sulfamethoxazole (Bactrim double strength) and ciprofloxacin, and has intermediate susceptibility to gentamicin?
In a patient with recurrent multidrug‑resistant urinary tract infections, recently hospitalized and currently receiving meropenem, piperacillin‑tazobactam, amoxicillin‑clavulanate (Augmentin), methenamine hippurate, and phenazopyridine, with normal white blood cell count and normal creatinine, should we obtain a vaginal swab for Gram stain and culture before starting intravaginal miconazole 2% cream?
What are the recommended treatments for the following conditions: dengue, malaria, typhoid, viral fever, acute gastroenteritis, pneumonia, urinary tract infection or pyelonephritis, cellulitis, leptospirosis, asthma exacerbation, COPD exacerbation, acute bronchitis, hypertensive urgency, heart failure, medically managed angina or acute coronary syndrome, diabetic ketoacidosis, hypoglycemia, hyponatremia, acute pancreatitis, gastritis, gastrointestinal bleed, and hepatitis or jaundice?
What are the indications, initial treatment options, and recommended investigations for vertigo, seizures, and migraine?
What are the recommended treatments for each complication of severe malaria?
What is the indication for antimicrobial therapy and how should the culture report be used to guide antibiotic selection?
What is the recommended definitive antimicrobial therapy for a gram‑positive organism identified in culture?
In a patient who requires urgent hemodialysis and is in shock with volume overload, how much ultrafiltration should be removed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.